Xr Securities LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Xr Securities LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $307,227 - $360,528	-300 Reduced 37.5%	500 $525,000
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $441,600 - $535,595	500 Added 166.67%	800 $840,000
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $90,269 - $99,335	-100 Reduced 25.0%	300 $288,000
Q4 2023 Feb 02, 2024	BUY	$775.18 - $881.7 $77,518 - $88,170	100 Added 33.33%	400 $351,000
Q3 2023 Oct 26, 2023	SELL	$692.45 - $844.37 $1.52 Million - $1.86 Million	-2,200 Reduced 88.0%	300 $246,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $1.05 Million - $1.25 Million	-1,500 Reduced 37.5%	2,500 $1.8 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $1.97 Million - $2.4 Million	2,900 Added 263.64%	4,000 $3.29 Million
Q4 2022 Jan 23, 2023	BUY	$705.89 - $766.39 $776,479 - $843,029	1,100 New	1,100 $0
Q4 2020 Jan 13, 2021	SELL	$478.3 - $607.98 $1.53 Million - $1.95 Million	-3,200 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$544.75 - $658.21 $1.2 Million - $1.45 Million	2,200 Added 220.0%	3,200 $246,000
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $789,312 - $1.03 Million	-1,600 Reduced 61.54%	1,000 $298,000
Q1 2020 Apr 09, 2020	BUY	$336.18 - $494.43 $874,068 - $1.29 Million	2,600 New	2,600 $254,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.